Tc Biopharm (Holdings) PLC (TCBWF) — 6-K Filings

All 6-K filings from Tc Biopharm (Holdings) PLC. Browse 22 Foreign Current Report reports with AI-powered summaries and risk analysis.

6-K Filings (22)

TC BioPharm Files 6-K Report — Nov 17, 2025 Risk: low
TC BioPharm (Holdings) plc, a biopharmaceutical company, filed a Form 6-K on November 17, 2025. The filing is a report of a foreign private issuer and does not
TC BioPharm Files 6-K Report — Oct 7, 2025 Risk: low
TC BioPharm (Holdings) plc filed a Form 6-K on October 7, 2025, reporting as a foreign private issuer. The company, incorporated in Scotland, operates in the bi
TC BioPharm Files Form 6-K for September 2025 — Sep 2, 2025 Risk: low
TC BioPharm (Holdings) plc, a biopharmaceutical company, filed a Form 6-K on September 2, 2025. This report is for the month of September 2025 and indicates the
TC BioPharm Files August 2025 6-K Report — Aug 5, 2025 Risk: low
TC BioPharm (Holdings) plc, a biopharmaceutical company, filed a Form 6-K on August 5, 2025. The filing is a report of a foreign private issuer for the month of
TC BioPharm Files 6-K Report — May 27, 2025 Risk: low
TC BioPharm (Holdings) plc filed a Form 6-K on May 27, 2025, reporting as a foreign private issuer. The company, previously known as TC BioPharm (Holdings) Ltd
TC BioPharm Files May 2025 6-K Report — May 6, 2025 Risk: low
TC BioPharm (Holdings) plc filed a Form 6-K on May 6, 2025, reporting its activities for the month of May 2025. The company, incorporated in Scotland, United Ki
TC BioPharm to be Delisted from Nasdaq — Mar 21, 2025 Risk: high
TC BioPharm (Holdings) plc announced on March 21, 2025, that it received notice from the Nasdaq Hearings Panel to delist its securities from The Nasdaq Stock Ma
TC BioPharm Changes ADS Ratio to 200:1 — Feb 10, 2025 Risk: medium
TC BioPharm (Holdings) PLC announced on February 5, 2025, a change in its American Depositary Shares (ADSs) to ordinary share ratio. The new ratio is one ADS re
TC BioPharm Faces Nasdaq Delisting Risk Over Bid Price — Jan 8, 2025 Risk: medium
On January 3, 2025, TC BioPharm (Holdings) plc received a notification from Nasdaq indicating that its American Depositary Shares (ADS) have not met the minimum
TC BioPharm Approves Special ADS Dividend — Dec 31, 2024 Risk: low
TC BioPharm (Holdings) plc announced on December 18, 2024, that its Board of Directors has approved a special dividend. Shareholders will receive 0.25 American
TC BioPharm Shareholder Meeting Approves All Resolutions — Dec 30, 2024 Risk: low
On December 30, 2024, TC BioPharm (Holdings) plc held a general meeting of shareholders where all proposed resolutions were passed. The company, also known as T
TC Biopharm Taps Wainwright for At-the-Market Offering — Dec 17, 2024 Risk: medium
On December 16, 2024, TC Biopharm (Holdings) PLC entered into an At The Market Offering Agreement with H.C. Wainwright & Co., LLC. This agreement allows the com
TC BioPharm Files 6-K Report — Dec 16, 2024 Risk: low
TC BioPharm (Holdings) plc, a biopharmaceutical company, filed a Form 6-K on December 16, 2024. The filing is a report of a foreign private issuer for the month
TC BioPharm Files 6-K for June 2024 Period — Nov 25, 2024 Risk: low
TC BioPharm (Holdings) plc, incorporated in Scotland, filed a Form 6-K on November 25, 2024, reporting for the period ending June 30, 2024. The company, previou
TC Biopharm Awards Bonuses to CEO and CFO — Oct 11, 2024 Risk: low
On September 2, 2024, TC Biopharm (Holdings) PLC's board of directors approved a one-time bonus of $125,000 for both CEO Bryan Kobel and CFO Martin Thorp. This
TC BioPharm Enters Securities Purchase Agreement — Aug 30, 2024 Risk: medium
On August 28, 2024, TC BioPharm (Holdings) plc entered into a Securities Purchase Agreement with accredited investors to issue and sell shares. The filing is a
TC BioPharm Regains Nasdaq Listing Compliance — Aug 23, 2024 Risk: medium
On August 21, 2024, TC BioPharm (Holdings) plc received a notice from the Nasdaq Stock Market stating that the company has regained compliance with the minimum
TC BioPharm Announces Public Offering Agreement — Aug 15, 2024 Risk: medium
On August 13, 2024, TC BioPharm (Holdings) plc entered into a Securities Purchase Agreement with an investor for a public offering. The filing does not specify
TC BioPharm Changes ADS Ratio — Aug 8, 2024 Risk: medium
TC BioPharm (Holdings) PLC announced on July 31, 2024, a change in its American Depositary Shares (ADSs) to ordinary share ratio. The new ratio is one ADS repre
TC BioPharm Files 6-K Report — Aug 6, 2024 Risk: low
TC BioPharm (Holdings) plc, a biotechnology company, filed a Form 6-K on August 6, 2024. The filing is a report of a foreign private issuer and does not contain
TC BioPharm Files 6-K Report — Jul 29, 2024 Risk: low
TC BioPharm (Holdings) plc filed a Form 6-K on July 29, 2024, reporting as a foreign private issuer. The company, previously known as TC BioPharm (Holdings) Ltd
TC BioPharm Files 6-K Report — Jul 1, 2024 Risk: low
TC BioPharm (Holdings) plc, a biotechnology company, filed a Form 6-K on July 1, 2024. The filing is a report of a foreign private issuer for the month of July

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX